Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report

Zhao-yu Lu; Hai-feng Yang; Yu Peng; Yin Li; Zi-chang Yin; Fu-hua Lu; Xu-sheng Liu

doi:10.1007/s11655-016-2098-1

Your Location：

Home >

Browse articles >

Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report

Updated：2021-08-27

- Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report
- Chinese Journal of Integrative Medicine Vol. 22, Issue 5, Pages: 390-393(2016)
- Affiliations：
  
  1. Department of Nephropathy, Guangdong Provincial Hospital of Traditional Chinese Medicine,Guangzhou,China
  2. Department of Pathology, Guangdong Provincial Hospital of Traditional Chinese Medicine,Guangzhou,China
  3. Kingmed Pathology Center,Guangzhou,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-016-2098-1
  CLC：
- Published：2016，
  
  Published Online：29 March 2016，
Scan for full text
Lu, Zy., Yang, Hf., Peng, Y. et al. Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report., Chin. J. Integr. Med. 22, 390–393 (2016). https://doi.org/10.1007/s11655-016-2098-1

Zhao-yu Lu, Hai-feng Yang, Yu Peng, et al. Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report. [J]. Chinese Journal of Integrative Medicine 22(5):390-393(2016)
Lu, Zy., Yang, Hf., Peng, Y. et al. Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report., Chin. J. Integr. Med. 22, 390–393 (2016). https://doi.org/10.1007/s11655-016-2098-1 DOI：

Zhao-yu Lu, Hai-feng Yang, Yu Peng, et al. Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report. [J]. Chinese Journal of Integrative Medicine 22(5):390-393(2016) DOI： 10.1007/s11655-016-2098-1.

摘要

Abstract

关键词

systemic lupus erythematosusNephrotic SyndromeLupus NephritisPrimary Biliary CirrhosisLower Extremity Edema

Keywords

systemic lupus erythematosusNephrotic SyndromeLupus NephritisPrimary Biliary CirrhosisLower Extremity Edema

references

Iskandar SS, Falk RJ, Jennette JC. Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 1992;42:1401–1407.

Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int 2003;63:1450–1461.

Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 1993;22:367–377.

Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, Leung N, et al. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol 2011;6:775–784.

Bridoux F, Hugue V, Coldefy O, Goujon JM, Bauwens M, Sechet A, et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunological features. Kidney Int 2002;62:1764–1775.

Dickenmann M, Schaub S, Nickeleit V, Mihatsch M, Steiger J, Brunner F. Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness. Am J Kidney Dis 2002;40:E9.

Ivanyi B, Degrell P. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. Nephrol Dial Transplant 2004;19:2166–2170.

Menon S, Zeng X, Valentini R. Fibrillary glomerulonephritis and renal failure in a child with systemic lupus erythematosus. Pediatr Nephrol 2009;24:1577–1581.

Yun YS, Song HC, Lee K, Choi EJ, Kim YS, Min JK, et al. Fibrillary glomerulonephritis in rheumatoid arthritis. Nephrology (Carlton) 2010;15:266–267.

Kornblihtt LI, Vassalllu PS, Heller PG, Lago NR, Alvarez CL, Molinas FC. Primary myelofibrosis in a patient who developed primary biliary cirrhosis, autoimmune hemolytic anemia and fibrillary glomerulonephritis. Ann Hematol 2008;87:1019–1020.

Markowitz GS, Cheng JT, Colvin RB, Trebbin WM, D'Agati VD. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 1998;9:2244–2252.

Asaba K, Tojo A, Onozato ML, Mimura N, Kido M, Goto A, et al. Fibrillary glomerulonephritis associated with essential thrombocytosis. Clin Exp Nephrol 2003;7:296–300.

Yang GC, Nieto R, Stachura I, Gallo GR. Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the Congo red-negative amyloid-like fibrils of fibrillary glomerulopathy. Am J Pathol 1992;141:409–419.

Brady HR. Fibrillary glomerulopathy. Kidney Int 1998;53:1421–1429.

Alpers CE, Kowalewska J. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 2008;19:34–37.

Javaugue V, Karras A, Glowacki F, McGregor B, Lacombe C, Goujon JM, et al. Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients. Am J Kidney Dis 2013;62:679–690.

Pronovost PH, Brady HR, Gunning ME, Espinoza O, Rennke HG. Clinical features, predictors of disease progression and results of renal transplantation in fibrillary immunotactoid glomerulopathy. Nephrol Dial Transplant 1996;11:837–842.

Samaniego M, Nadasdy GM, Laszik Z, Nadasdy T. Outcome of renal transplantation in fibrillary glomerulonephritis. Clin Nephrol 2001;55:159–166.

Tune BM, Mendoza SA. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. J Am Soc Nephrol 1997;8:824–832.

Collins M, Navaneethan SD, Chung M, Sloand J, Goldman B, Appel G, et al. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis 2008;52:1158–1162.

Yang J, Fan LH. Clinical observation of primary nephrotic syndrome treated by prednisone and Tripterygium wilfordii. Chin Prac Med (Chin) 2010;5:161–162.

Zhao DG, Zhao X. Synergism of Tripterygium glycosides and prednisone for the complementary treatment of nephrotic syndrome. J Changchun Univ Tradit Chin Med (Chin) 1997;13:20–21.

Chen Y, Gong Z, Chen X, Tang L, Zhao X, Yuan Q, et al. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome. Cochrane Database Syst Rev 2013;8:CD008568.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effect of Xuebijing injection (血必净注射液) on systemic lupus erythematosus in mice

A case of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome treated with chinese herbs

Efficacy of ursodeoxycholic acid combined with Tongdan Decoction (通胆汤) on immunological indices and histopathological changes in primary biliary cirrhosis patients

Systemic lupus erythematosus complicated with femoral head ischemic necrosis treated by Chinese medicine therapy for activating blood and dredging collaterals method

Regulatory effect of Langchuang serial recipes on T-lymphocyte subsets Th and Tc in patients with systemic lupus erythematosus

Related Author

No data

Related Institution

Burns Institute, First Hospital Affiliated to the Chinese PLA General Hospital

Chinese Center for Disease Control and Prevention

Department of Dermatology, Xijing Hospital, Fourth Military Medical University

Emergency Department

Radiology Department

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰